TP53 and plasma cell myeloma: Accumulating evidence reveals that TX prevents growth through accumulation of p53, p21, cell cycle arrest, and apoptosis in fibroblast cells, human gastric cancer cells, myeloma cells, lymphoid malignant cells, and acute promyelocytic leukemia (APL) cell lines.